» Articles » PMID: 31121993

Substance Abuse and Male Hypogonadism

Overview
Journal J Clin Med
Specialty General Medicine
Date 2019 May 25
PMID 31121993
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Progressive deterioration of male reproductive function is occurring in Western countries. Environmental factors and unhealthy lifestyles have been implicated in the decline of testosterone levels and sperm production observed in the last fifty years. Among unhealthy lifestyles, substance and drug abuse is a recognized cause of possible alterations of steroidogenesis and spermatogenesis. Alcohol, opioids and anabolic-androgenic steroids are capable to reduce testosterone production in male interfering with testicular and/or hypothalamic-pituitary function. Other substances such as nicotine, cannabis, and amphetamines alter spermatogenesis inducing oxidative stress and subsequent apoptosis in testicular tissue. Substance and drug abuse is a potentially reversible cause of hypogonadism, defined as the failure of the testis to produce physiological concentrations of testosterone and/or a normal number of spermatozoa. The identification of the abuse is important because the withdrawal of substance intake can reverse the clinical syndrome. This review summarizes the most important clinical and experimental evidence on the effect of substance abuse on testosterone and sperm production.

Citing Articles

Heat-not-burn technology affects plasma testosterone levels and markers of inflammation, oxidative stress in the testes of rats.

Granata S, Morosini C, Valerii M, Fagiolino I, Sangiorgi S, Ghini S Front Toxicol. 2025; 6:1515850.

PMID: 39902465 PMC: 11788375. DOI: 10.3389/ftox.2024.1515850.


The Rise of Fentanyl: Molecular Aspects and Forensic Investigations.

Barletta C, Di Natale V, Esposito M, Chisari M, Cocimano G, Di Mauro L Int J Mol Sci. 2025; 26(2).

PMID: 39859160 PMC: 11765396. DOI: 10.3390/ijms26020444.


Lifestyle Medicine's Role in Common Hormonal Disorders: A Case-Based Discussion.

Gulati M Am J Lifestyle Med. 2024; 18(5):638-647.

PMID: 39309326 PMC: 11412375. DOI: 10.1177/15598276241242012.


Klinefelter Syndrome Diagnosis Masked by Opioid Use Disorder.

Soliman M, Delroux-Spalding K, Voelckers A Cureus. 2024; 16(7):e64870.

PMID: 39156457 PMC: 11330540. DOI: 10.7759/cureus.64870.


Probiotics as Potential Therapeutic Agents: Safeguarding Skeletal Muscle against Alcohol-Induced Damage through the Gut-Liver-Muscle Axis.

Sausa M, Fucarino A, Paladino L, Zummo F, Fabbrizio A, Di Felice V Biomedicines. 2024; 12(2).

PMID: 38397983 PMC: 10886686. DOI: 10.3390/biomedicines12020382.


References
1.
Dias T, Alves M, Bernardino R, Martins A, Moreira A, Silva J . Dose-dependent effects of caffeine in human Sertoli cells metabolism and oxidative profile: relevance for male fertility. Toxicology. 2014; 328:12-20. DOI: 10.1016/j.tox.2014.12.003. View

2.
Park B, McPartland J, Glass M . Cannabis, cannabinoids and reproduction. Prostaglandins Leukot Essent Fatty Acids. 2003; 70(2):189-97. DOI: 10.1016/j.plefa.2003.04.007. View

3.
Barenys M, Macia N, Camps L, de Lapuente J, Gomez-Catalan J, Gonzalez-Linares J . Chronic exposure to MDMA (ecstasy) increases DNA damage in sperm and alters testes histopathology in male rats. Toxicol Lett. 2009; 191(1):40-6. DOI: 10.1016/j.toxlet.2009.08.002. View

4.
Banerjee A, Singh A, Srivastava P, Turner H, Krishna A . Effects of chronic bhang (cannabis) administration on the reproductive system of male mice. Birth Defects Res B Dev Reprod Toxicol. 2011; 92(3):195-205. DOI: 10.1002/bdrb.20295. View

5.
Thistle J, Graubard B, Braunlin M, Vesper H, Trabert B, Cook M . Marijuana use and serum testosterone concentrations among U.S. males. Andrology. 2017; 5(4):732-738. PMC: 5660879. DOI: 10.1111/andr.12358. View